Some interesting news related to Memorial Sloan Kettering…..
- Currently, the position of a number of organizations is that guidelines for population-based screening for melanoma are not needed since there is no clinical trial evidence of a benefit. However, at a meeting of the Hawaii Dermatology Seminar, Dr. Allan C. Halpern, Chief of the Dermatology Service at MSK, reported that there is an increase in the demand for screening for melanoma. There has been a dramatic increase in new cases of melanoma. Dr. Halpern says there may be a million people in the US. who have had melanoma who need follow-up visits and their family members need to be tested as well. Continue reading